Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

ClinicalTrials.gov ID: NCT00297115

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00297115. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 4:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Roflumilast on Exacerbation Rate in Patients With COPD. The HERMES Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of the study is to compare the effect of roflumilast on exacerbation rate and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Roflumilast will be administered orally once daily in the morning at one dose level. The study duration will be up to 56 weeks. The study will provide further data on safety and tolerability of roflumilast. For additional information (for US patients only) see www.COPDSTUDY.net or dial 866-788-2673 (toll free).

Study identification

NCT ID
NCT00297115
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,568 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2006 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Nov 7, 2016

2006 – 2008

United States locations

U.S. sites
151
U.S. states
40
U.S. cities
134
Facility City State ZIP Site status
Altana Pharma/Nycomed Investigational Site Bayou La Batre Alabama 36509 —
Altana Pharma/Nycomed Investigational Site Birmingham Alabama 35249 —
Altana Pharma/Nycomed Investigational Site Birmingham Alabama 35294 —
Altana Pharma/Nycomed Investigational Site Huntsville Alabama 35801 —
Altana Pharma/Nycomed Investigational Site Bullhead City Arizona 85442 —
Altana Pharma/Nycomed Investigational Site Phoenix Arizona 85012 —
Altana Pharma/Nycomed Investigational Site Phoenix Arizona 85023 —
Altana Pharma/Nycomed Investigational Site Fort Smith Arkansas 72917 —
Altana Pharma/Nycomed Investigational Site Little Rock Arkansas 72205 —
Altana Pharma/Nycomed Investigational Site Anaheim California 92801 —
Altana Pharma/Nycomed Investigational Site Burbank California 91505 —
Altana Pharma/Nycomed Investigational Site Carlsbad California 92008 —
Altana Pharma/Nycomed Investigational Site Fresno California 93720 —
Altana Pharma/Nycomed Investigational Site Lakewood California 90712 —
Altana Pharma/Nycomed Investigational Site Long Beach California 90822 —
Altana Pharma/Nycomed Investigational Site Los Alamitos California 90720 —
Altana Pharma/Nycomed Investigational Site Los Angeles California 90033 —
Altana Pharma/Nycomed Investigational Site Roseville California 95678 —
Altana Pharma/Nycomed Investigational Site Sacramento California 95831 —
Altana Pharma/Nycomed Investigational Site San Diego California 92103 —
Altana Pharma/Nycomed Investigational Site San Diego California 92120 —
Altana Pharma/Nycomed Investigational Site Sepulveda California 91343 —
Altana Pharma/Nycomed Investigational Site Stockton California 95207 —
Altana Pharma/Nycomed Investigational Site Denver Colorado 80206 —
Altana Pharma/Nycomed Investigational Site Waterbury Connecticut 6708 —
Altana Pharma/Nycomed Investigational Site Washington D.C. District of Columbia 20017 —
Altana Pharma/Nycomed Investigational Site Clearwater Florida 33756 —
Altana Pharma/Nycomed Investigational Site DeLand Florida 32720 —
Altana Pharma/Nycomed Investigational Site Fort Lauderdale Florida 33316 —
Altana Pharma/Nycomed Investigational Site Jacksonville Florida 32204 —
Altana Pharma/Nycomed Investigational Site Miami Florida 33173 —
Altana Pharma/Nycomed Investigational Site Miami Florida 33176 —
Altana Pharma/Nycomed Investigational Site Miami Beach Florida 33140 —
Altana Pharma/Nycomed Investigational Site Ocala Florida 34471 —
Altana Pharma/Nycomed Investigational Site Ormand Beach Florida 32174 —
Altana Pharma/Nycomed Investigational Site Port Orange Florida 33127 —
Altana Pharma/Nycomed Investigational Site Tamarac Florida 33321 —
Altana Pharma/Nycomed Investigational Site Vero Beach Florida 32960 —
Altana Pharma/Nycomed Investigational Site Atlanta Georgia 30342 —
Altana Pharma/Nycomed Investigational Site Blue Ridge Georgia 30513 —
Altana Pharma/Nycomed Investigational Site Columbus Georgia 31901 —
Altana Pharma/Nycomed Investigational Site Decatur Georgia 30033 —
Altana Pharma/Nycomed Investigational Site Fort Eisenhower Georgia 30905 —
Altana Pharma/Nycomed Investigational Site Marietta Georgia 30060 —
Altana Pharma/Nycomed Investigational Site Rincon Georgia 594 —
Altana Pharma/Nycomed Investigational Site Savannah Georgia 31406 —
Altana Pharma/Nycomed Investigational Site Twin Falls Idaho 83301 —
Altana Pharma/Nycomed Investigational Site Champaign Illinois 61820 —
Altana Pharma/Nycomed Investigational Site Chicago Illinois 60611 —
Altana Pharma/Nycomed Investigational Site Elk Grove Village Illinois 60007 —
Altana Pharma/Nycomed Investigational Site North Chicago Illinois 60064 —
Altana Pharma/Nycomed Investigational Site Peoria Illinois 61603 —
Altana Pharma/Nycomed Investigational Site River Forest Illinois 60305 —
Altana Pharma/Nycomed Investigational Site Elkhart Indiana 46514 —
Altana Pharma/Nycomed Investigational Site Indianapolis Indiana 46202 —
Altana Pharma/Nycomed Investigational Site Indianapolis Indiana 46254 —
Altana Pharma/Nycomed Investigational Site New Albany Indiana 47150 —
Altana Pharma/Nycomed Investigational Site Dubuque Iowa 52001 —
Altana Pharma/Nycomed Investigational Site Fort Dodge Iowa 50501 —
Altana Pharma/Nycomed Investigational Site Iowa City Iowa 52242 —
Altana Pharma/Nycomed Investigational Site Waterloo Iowa 50702 —
Altana Pharma/Nycomed Investigational Site Olathe Kansas 66061 —
Altana Pharma/Nycomed Investigational Site Topeka Kansas 66606 —
Altana Pharma/Nycomed Investigational Site Campbellsville Kentucky 42718 —
Altana Pharma/Nycomed Investigational Site Hazard Kentucky 41701 —
Altana Pharma/Nycomed Investigational Site Louisville Kentucky 40207 —
Altana Pharma/Nycomed Investigational Site Metairie Louisiana 70006 —
Altana Pharma/Nycomed Investigational Site West Monroe Louisiana 71291 —
Altana Pharma/Nycomed Investigational Site Columbia Maryland 21044 —
Altana Pharma/Nycomed Investigational Site Boston Massachusetts 02114 —
Altana Pharma/Nycomed Investigational Site Brighton Michigan 48114 —
Altana Pharma/Nycomed Investigational Site Interlochen Michigan 49643 —
Altana Pharma/Nycomed Investigational Site Livonia Michigan 48152 —
Altana Pharma/Nycomed Investigational Site Portage Michigan 49002 —
Altana Pharma/Nycomed Investigational Site Saginaw Michigan 48602 —
Altana Pharma/Nycomed Investigational Site Duluth Minnesota 55805 —
Altana Pharma/Nycomed Investigational Site Edina Minnesota 55435 —
Altana Pharma/Nycomed Investigational Site Minneapolis Minnesota 55407 —
Altana Pharma/Nycomed Investigational Site Rochester Minnesota 55905 —
Altana Pharma/Nycomed Investigational Site Chesterfield Missouri 63017 —
Altana Pharma/Nycomed Investigational Site Jefferson City Missouri 65101 —
Altana Pharma/Nycomed Investigational Site Kansas City Missouri 64106 —
Altana Pharma/Nycomed Investigational Site Kansas City Missouri 64111 —
Altana Pharma/Nycomed Investigational Site St Louis Missouri 63122 —
Altana Pharma/Nycomed Investigational Site St Louis Missouri 63141 —
Altana Pharma/Nycomed Investigational Site Sunset Missouri 70584 —
Altana Pharma/Nycomed Investigational Site Bozeman Montana 59718 —
Altana Pharma/Nycomed Investigational Site Butte Montana 59701 —
Altana Pharma/Nycomed Investigational Site Omaha Nebraska 68131 —
Altana Pharma/Nycomed Investigational Site Las Vegas Nevada 89123 —
Altana Pharma/Nycomed Investigational Site Las Vegas Nevada 89176 —
Altana Pharma/Nycomed Investigational Site Absecon New Jersey 08201 —
Altana Pharma/Nycomed Investigational Site Hamilton New Jersey 08610 —
Altana Pharma/Nycomed Investigational Site South Bound Brook New Jersey 08880 —
Altana Pharma/Nycomed Investigational Site Camillus New York 13031 —
Altana Pharma/Nycomed Investigational Site Corning New York 14830 —
Altana Pharma/Nycomed Investigational Site Cortland New York 13045 —
Altana Pharma/Nycomed Investigational Site New Hyde Park New York 11040 —
Altana Pharma/Nycomed Investigational Site New Hyde Park New York 11042 —
Altana Pharma/Nycomed Investigational Site Syracuse New York 13210 —
Altana Pharma/Nycomed Investigational Site Charlotte North Carolina 28207 —
Altana Pharma/Nycomed Investigational Site Huntersville North Carolina 28070 —
Altana Pharma/Nycomed Investigational Site Winston-Salem North Carolina 27103 —
Altana Pharma/Nycomed Investigational Site Canton Ohio 44718 —
Altana Pharma/Nycomed Investigational Site Cincinnati Ohio 45231 —
Altana Pharma/Nycomed Investigational Site Columbus Ohio 43215 —
Altana Pharma/Nycomed Investigational Site Sylvania Ohio 43560 —
Altana Pharma/Nycomed Investigational Site Toledo Ohio 43608 —
Altana Pharma/Nycomed Investigational Site Toledo Ohio 43614 —
Altana Pharma/Nycomed Investigational Site Toledo Ohio 43617 —
Altana Pharma/Nycomed Investigational Site Oklahoma City Oklahoma 73120 —
Altana Pharma/Nycomed Investigational Site Medford Oregon 97504 —
Altana Pharma/Nycomed Investigational Site Portland Oregon 97220 —
Altana Pharma/Nycomed Investigational Site Erie Pennsylvania 16506 —
Altana Pharma/Nycomed Investigational Site Hershey Pennsylvania 17033 —
Altana Pharma/Nycomed Investigational Site Philadelphia Pennsylvania 19107 —
Altana Pharma/Nycomed Investigational Site Philadelphia Pennsylvania 19140 —
Altana Pharma/Nycomed Investigational Site Pittsburgh Pennsylvania 15221 —
Altana Pharma/Nycomed Investigational Site Stoneboro Pennsylvania 16153 —
Altana Pharma/Nycomed Investigational Site Swarthmore Pennsylvania 19081 —
Altana Pharma/Nycomed Investigational Site Johnston Rhode Island 2919 —
Altana Pharma/Nycomed Investigational Site Charleston South Carolina 29406 —
Altana Pharma/Nycomed Investigational Site Greenville South Carolina 29605 —
Altana Pharma/Nycomed Investigational Site Greenville South Carolina 29615 —
Altana Pharma/Nycomed Investigational Site Greer South Carolina 29651 —
Altana Pharma/Nycomed Investigational Site Union South Carolina 29379 —
Altana Pharma/Nycomed Investigational Site Williamston South Carolina 29697 —
Altana Pharma/Nycomed Investigational Site Johnson City Tennessee 37604 —
Altana Pharma/Nycomed Investigational Site Knoxville Tennessee 37920 —
Altana Pharma/Nycomed Investigational Site Memphis Tennessee 38163 —
Altana Pharma/Nycomed Investigational Site Nashville Tennessee 37203 —
Altana Pharma/Nycomed Investigational Site New Tazewell Tennessee 37825 —
Altana Pharma/Nycomed Investigational Site Boerne Texas 78006 —
Altana Pharma/Nycomed Investigational Site Corsicana Texas 75110 —
Altana Pharma/Nycomed Investigational Site Fort Worth Texas 76109 —
Altana Pharma/Nycomed Investigational Site Houston Texas 77005 —
Altana Pharma/Nycomed Investigational Site Houston Texas 77024 —
Altana Pharma/Nycomed Investigational Site Hurst Texas 76054 —
Altana Pharma/Nycomed Investigational Site McKinney Texas 75069 —
Altana Pharma/Nycomed Investigational Site San Antonio Texas 78205 —
Altana Pharma/Nycomed Investigational Site San Antonio Texas 78229 —
Altana Pharma/Nycomed Investigational Site Seguin Texas 78155 —
Altana Pharma/Nycomed Investigational Site Tyler Texas 75708 —
Altana Pharma/Nycomed Investigational Site Salt Lake City Utah 84107 —
Altana Pharma/Nycomed Investigational Site Salt Lake City Utah 84124 —
Altana Pharma/Nycomed Investigational Site Lynchburg Virginia 24501 —
Altana Pharma/Nycomed Investigational Site Seattle Washington 98104 —
Altana Pharma/Nycomed Investigational Site Spokane Washington 99216 —
Altana Pharma/Nycomed Investigational Site Charleston West Virginia 25304 —
Altana Pharma/Nycomed Investigational Site Glendale Wisconsin 53212 —
Altana Pharma/Nycomed Investigational Site Glendale Wisconsin 53217 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 136 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00297115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2016 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.